QQ客服 官方微博 反馈留言

	On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy
	Wei, Lai; Shang, Jia; Xie, Qing; Jia, Zhansheng; Gao, Pujun; Shi, Junping; Chen, Xinyue; Wang, Jiefei; Xu, Min; Zhang, Liaoyun
刊名	HEPATOLOGY
	2018
卷号	Vol.68页码:229A-230A
ISSN号	0270-9139
URL标识	查看原文
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/1834361
专题	四川大学
作者单位	1.Second Hosp Nanjing, Dept Hepatol, Nanjing, Jiangsu, Peoples R China 2.Fourth Mil Med Univ, Tangdu Hosp, Chinese PLA, Ctr Diag & Treatment Infect Dis, Xian, Shaanxi, Peoples R China 3.Shanxi Med Univ, Hosp 1, Dept Infect Dis, Taiyuan, Shanxi, Peoples R China 4.Huazhong Univ Sci & Technol, Dept Infect Dis, Inst Infect & Immunol, Affiliated Union Hosp,Tongji Med Coll, Wuhan, Hubei, Peoples R China 5.Peoples Liberat Army, Hosp 81, Dept Infect Dis, Nanjing, Jiangsu, Peoples R China 6.Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Infect Dis, Xian, Shaanxi, Peoples R China 7.Glaxosmithkline China R 8.Jilin Univ, Hosp 1, Dept Hepatol, Changchun, Jilin, Peoples R China 9.Capital Med Univ, Beijing Youan Hosp, Int Med Dept, Beijing, Peoples R China 10.Glaxosmithkline China Investment Co Ltd, Med Affairs, Beijing, Peoples R China
推荐引用方式 GB/T 7714	Wei, Lai,Shang, Jia,Xie, Qing,et al. On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy[J]. HEPATOLOGY,2018,Vol.68:229A-230A.
APA	Wei, Lai.,Shang, Jia.,Xie, Qing.,Jia, Zhansheng.,Gao, Pujun.,...&Zhang, Liaoyun.(2018).On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy.HEPATOLOGY,Vol.68,229A-230A.
MLA	Wei, Lai,et al."On-Treatment ALT Normalization Has No Statistical Significant Impact on Liver Stiffness Regression in Chinese Chronic Hepatitis B Patients with Advanced Fibrosis or Cirrhosis Receiving Tenofovir Disoproxil Fumarate Therapy".HEPATOLOGY Vol.68(2018):229A-230A.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。